Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zevra Therapeutics

9.19
-0.0700-0.76%
Post-market: 9.190.00000.00%16:20 EDT
Volume:722.79K
Turnover:6.61M
Market Cap:502.51M
PE:-4.93
High:9.41
Open:9.40
Low:9.02
Close:9.26
Loading ...

Press Release: Zevra Announces Final Results of 2025 Annual Meeting of Stockholders

Dow Jones
·
30 May

Zevra Therapeutics (ZVRA) Receives a Buy from Citizens JMP

TIPRANKS
·
27 May

BRIEF-Zevra Therapeutics ISS, Glass Lewis & Egan-Jones Recommend Zevra Stockholders Vote For Co's Director Nominees

Reuters
·
21 May

Zevra announces 3 proxy advisory firms recommended vote ‘FOR’ Dixon, Favorito

TIPRANKS
·
21 May

Zevra Therapeutics Price Target Maintained With a $25.00/Share by Cantor Fitzgerald

Dow Jones
·
14 May

Zevra Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Zevra Therapeutics Q1 Net Loss Narrows, Revenue Rises; Shares Gain After Hours

MT Newswires Live
·
14 May

Zevra Therapeutics reports Q1 EPS (6c), consensus (18c)

TIPRANKS
·
14 May

BRIEF-Zevra Therapeutics Q1 Operating Expenses USD 22.803 Million

Reuters
·
14 May

Zevra Therapeutics Q1 EPS $(0.06) Beats $(0.20) Estimate, Sales $20.40M Beat $16.96M Estimate

Benzinga
·
14 May

Press Release: Zevra Reports First Quarter 2025 Financial Results and Corporate Update

Dow Jones
·
14 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Zevra Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
10 May

Zevra Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
06 May

Zevra Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
03 May

Zevra Therapeutics urges stockholders to vote for director nominees

TIPRANKS
·
21 Apr

Zevra Therapeutics Inc - Board Recommends Voting 'for' Wendy L. Dixon and Tamara a. Favorito

THOMSON REUTERS
·
21 Apr

Zevra Files Definitive Proxy Statement and Mails Letter to Stockholders

GlobeNewswire
·
21 Apr

Zevra Therapeutics announces publication on arimoclomol

TIPRANKS
·
17 Apr

Zevra Announces Publication of Miplyffa® Mechanism of Action Manuscript in Molecular Genetics and Metabolism

THOMSON REUTERS
·
17 Apr